QSAR Modeling and Molecular Docking Studies of 3,5-Disubstituted Indole Derivatives as Pim1 Inhibitors for Combating Hematological Cancer

Document Type : Regular Article

Authors

1 Laboratory of Processes, Materials, and Environment (LPME), Faculty of Science and Technology, Sidi Mohamed Ben Abdellah University, Fez, Morocco

2 MCNS Laboratory, Faculty of Sciences, Moulay Ismail University, Meknes, Morocco

10.22036/pcr.2023.417665.2425

Abstract

Cancer has become a global health concern, with escalating mortality rates in the 21st century, leading the World Health Organization to recognize it as one of the deadliest diseases. In their search for new anticancer therapeutic agents, researchers have identified the 3,5-disubstituted Indole derivatives as potential therapeutic agents capable of targeting the Proviral integration of moloney (Pim) kinases that correlate to hematological cancers. This study aims to investigate a series of 3,5-disubstituted indole derivatives as potent inhibitors of Pim1 kinase. Different computational chemistry techniques were utilized, including 2D-QSAR and molecular docking, to design novel inhibitors for targeting Pim1. The analysis of 2D-QSAR results showed that the inhibitory activity might be predicted with high accuracy (R²test = 0.96) using a classical statistical modeling technique, namely partial least squares regression.The six inhibitors that were identified as highly bio-active, were subjected to the docking study, and the results highlighted the important Pi-Alkyl interactions rising between the ligands and the Pim-1 kinase receptor (PDBcode:5DWR),which may enhance the binding of the ligand to a hydrophobic pocket on the target receptor. Overall, the combination of 2D-QSAR, moleculardocking, and ADMETanalysis has provided valuable insights and potential avenues for further exploration in the development of effective hematologicalanticancer agents.

Graphical Abstract

QSAR Modeling and Molecular Docking Studies of 3,5-Disubstituted Indole Derivatives as Pim1 Inhibitors for Combating Hematological Cancer

Keywords

Main Subjects

Physical Chemistry Research
Volume 12, Issue 3 - Serial Number 43
September 2024
Pages 631-645

Files

History

  • Receive Date: 23 September 2023
  • Revise Date: 25 November 2023
  • Accept Date: 26 November 2023

Share

How to cite

Statistics